You can only view this photo if you sign up to XING.

Kazuko Curtin

Founder and CEO

(The company name is only visible to registered members)

Austin
United States

Contact Kazuko Curtin!

All you need to do is sign up for free on XING.

Contact now

Personal information

Wants

To Network

Professional experience

2004 - present

(Only visible for registered members)

Employment status

Executive

Educational background

Languages

English

About me

CARE Clinics, founded by Kazuko Curtin in Austin, Texas, was instituted out of a desire to help children afflicted with autism, as well as their parents. Since 2004, CARE Clinics has developed innovative and promising treatments for children exhibiting a range of autism spectrum disorders (ASDs), including Autism, Asperger syndrome, childhood disintegrative disorder, pervasive developmental disorder-not otherwise specified (commonly known as PDD-NOS), Attention-Deficit/Hyperactivity Disorder (ADHD), Rett syndrome, and Attention Deficit Disorder (ADD). Kazuko Curtin’s approach to understanding and treating these disorders is different from conventional medicine. CARE Clinics views the behaviors grouped under these labels from a genetic standpoint, taking into account how dysfunctions are a combination of environmental toxicity and sensitivity. Kazuko Curtin has been developing treatments with CARE Clinics since her firstborn son was diagnosed with autism at age three. The safe and modern techniques Kazuko Curtin and CARE Clinics utilize allow them to determine a course of treatment that is most beneficial to the child and their parents. Ms. Curtin and CARE Clinics develop a personalized genetic profile treatment regime based on scientific analysis of a child’s tissue samples. CARE Clinics’ treatment of autism and ADD/ADHD as diseases with biomedical roots provides a unique insight that has already helped many patients and their parents. Kazuko Curtin currently resides in Austin, Texas, but she frequently travels across the country, speaking on ASDs and educating people about her newest treatments.